Cargando…
Targeted imaging and inhibition of triple-negative breast cancer metastases by a PDGFRβ aptamer
While the overall mortality for breast cancer has recently declined, management of triple-negative breast cancer (TNBC) is still challenging because of its aggressive clinical behavior and the lack of targeted therapies. Genomic profiling studies highlighted the high level of heterogeneity of this c...
Autores principales: | Camorani, Simona, Hill, Billy Samuel, Collina, Francesca, Gargiulo, Sara, Napolitano, Maria, Cantile, Monica, Di Bonito, Maurizio, Botti, Gerardo, Fedele, Monica, Zannetti, Antonella, Cerchia, Laura |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6217067/ https://www.ncbi.nlm.nih.gov/pubmed/30429893 http://dx.doi.org/10.7150/thno.27798 |
Ejemplares similares
-
Aptamer targeted therapy potentiates immune checkpoint blockade in triple-negative breast cancer
por: Camorani, Simona, et al.
Publicado: (2020) -
Novel Aptamers Selected on Living Cells for Specific Recognition of Triple-Negative Breast Cancer
por: Camorani, Simona, et al.
Publicado: (2020) -
TNBC Challenge: Oligonucleotide Aptamers for New Imaging and Therapy Modalities
por: Camorani, Simona, et al.
Publicado: (2018) -
Inhibition of Bone Marrow-Derived Mesenchymal Stem Cells Homing Towards Triple-Negative Breast Cancer Microenvironment Using an Anti-PDGFRβ Aptamer
por: Camorani, Simona, et al.
Publicado: (2017) -
Aptamer-mediated impairment of EGFR-integrin αvβ3 complex inhibits vasculogenic mimicry and growth of triple-negative breast cancers
por: Camorani, Simona, et al.
Publicado: (2017)